IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lynx1 Capital Management LP

Q4 2021 Holdings

Filed 2022-02-14 | 10 holdings | $114.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Merus N VCOMN5749R100$24.9K783,39821.7%
Travere Therapeutics Inc(TVTX)COM89422G107$22.9K737,06120.0%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$17.5K1,261,92715.3%
Bellus Health Inc New(BLU)COM NEW07987C204$16.1K2,003,11414.1%
Immunogen Inc(IMGNEUR)COM45253H101$15.8K2,129,53113.8%
Pardes Biosciences IncCOM69945Q105$6.6K401,5935.7%
Theseus Pharmaceuticals IncCOM88369M101$5.2K409,3584.5%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$4.1K1,224,9683.6%
Pieris Pharmaceuticals IncCOM720795103$1.4K383,2661.3%
Otonomy IncCOM68906L105$6230,0000.1%